๐งช Heading to #AACR2025 and interested in advancing antibody discovery technologies?
Join us at ๐ฃ๐ผ๐๐๐ฒ๐ฟ ๐๐๐ฌ๐ฌ๐ฏ on ๐ฆ๐๐ป๐ฑ๐ฎ๐ ๐๐ฝ๐ฟ๐ถ๐น ๐ฎ๐ณ during the afternoon poster session where we will present our most recent data from MImAbs SAS.
๐ Highlight: We employed the ๐๐ฒ๐ฎ๐ฐ๐ผ๐ปยฎ ๐๐ถ๐ป๐ด๐น๐ฒ-๐ ๐ฐ๐ฒ๐น๐น ๐๐ฐ๐ฟ๐ฒ๐ฒ๐ป๐ถ๐ป๐ด ๐ฝ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ to isolate novel monoclonal antibodies with ๐ต๐ถ๐ด๐ต ๐๐ฝ๐ฒ๐ฐ๐ถ๐ณ๐ถ๐ฐ๐ถ๐๐ toward cancer-associated targets. Our approach enables rapid functional screening at the single-cell level, accelerating the path from B cell to candidate.
If you're interested in learning more or discussing potential collaborations, feel free to ๐ฟ๐ฒ๐ฎ๐ฐ๐ต ๐ผ๐๐ ๐๐ผ ๐๐ ๐๐ผ ๐๐ฐ๐ต๐ฒ๐ฑ๐๐น๐ฒ ๐ฎ ๐บ๐ฒ๐ฒ๐๐ถ๐ป๐ด ๐ฑ๐๐ฟ๐ถ๐ป๐ด ๐๐ต๐ฒ ๐ฐ๐ผ๐ป๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ weโd be happy to connect!
#AACR2025 #AntibodyDiscovery #CancerResearch #SingleBCellScreening #BeaconPlatform #Bruker #ImmunoOncology #TranslationalResearch #MImAbs